SANTA MONICA, Calif., April 30, 2015 /PRNewswire/ -- Dean Kamen, inventor and outspoken advocate for science and technology education, will speak on the robotic prosthesis, The Luke Arm, at the upcoming BIOMEDevice Boston event at the Boston Convention and Exhibition Center, May 6, 2015. Kamen will be the keynote speaker at the complimentary Center Stage in the expo hall. UBM Canon's BIOMEDevice Boston is co-located with Design and Manufacturing New England, Electronics New England, PLASTEC New England, Quality Expo Showcase and ESC. Attendees at all of these trade events will have the opportunity to hear this free presentation. The keynote is co-sponsored by UBM Canon and the 2015 MassMEDIC Annual Conference as part of Massachusetts Medtech Week.
The Luke Arm, named after Luke Skywalker, was developed by Kamen and his team at DEKA Research and Development Corp., in Manchester, N.H. This prosthesis, also called the DEKA Arm System, received FDA approval last year. The FDA reports that this is the first approved prosthetic arm that "translates signals from a person's muscles to perform complex tasks." The arm allows its wearer multiple simultaneous movements and a delicate, controlled grip. Development of this prosthesis is part of a Defense Advanced Research Projects Agency (DARPA) program, Revolutionizing Prosthetics, to aide amputees, particularly the many veteran amputees.
About UBM Canon
UBM Canon is the leading B-to-B event producer, publisher, and digital media company for the world's $3 trillion advanced, technology-based manufacturing industry. Our print and electronic products deliver trusted information to the advanced manufacturing market and leverage our proprietary 1.3 million name database to connect suppliers with buyers and purchase influencers. We produce more than 50 events and conferences in a dozen countries, connecting manufacturing professionals from around the globe. UBM Canon is part of UBM plc (UBM.L) a global provider of media and information services for professional B-to-B communities and markets.
SOURCE UBM Canon